Initial funding of USD 29 million to support development of Basilea’s clinical stage first-in-class antifungals, fosmanogepix ...

Basilea Pharmaceutica has entered into a multi-year agreement with the Biomedical Advanced Research and Development Authority ...

Hunan Engineering Technology Research Center of Featured Aquatic Resources Utilization, Fisheries College, Hunan Agricultural University Changsha, Hunan, 410128, China State Key Laboratory of ...

Invasive fungal infections are one of the major causes of morbidity and mortality in neonates and immunocompromised children. Early diagnosis and prompt initiation of appropriate antifungal ...

Sanitizing clothing, equipment, machinery and pruning tools also will be critical. And fungicidal treatments can also help keep the disease under control. However, the most effective chemical ...

Initial funding of USD 29 million to support development of Basilea's clinical stage first-in-class antifungals, fosmanogepix and BAL2062 -- ...